Krsnaa DiagnosticsQ1 FY24

Krsnaa Diagnostics Q1 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹518.7P/E: 16.7Market Cap: ₹1.7K CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

No

Order

Yes

Capex

Yes

2 of 5 growth signals are positive.

Full analysis

Revenue guidance

Category 2
  • The company targets a revenue growth of 30-35% year-on-year for the next two years excluding Rajasthan.
  • With Rajasthan tender included, the growth rate will be significantly higher.
  • Rajasthan is expected to contribute close to INR 300 crores in revenue in FY25.
  • Total revenue including Rajasthan for FY25 is projected to approach INR 1100 crores.
  • New project deployments in Assam, Odisha, BMC, and Maharashtra are expected to drive growth.
  • Ramp-up in existing projects like Punjab and Himachal Pradesh continues to contribute to increasing revenues.
  • Expansion in pathology service contribution is expected to improve overall revenue mix over time.
  • There is headroom for increased tele-reporting and utilization of installed equipment capacity, indicating further volume growth potential.

See what Krsnaa Diagnostics management said on margin guidance — free account, 30 seconds.

Fundraise plans

No
  • Currently, Krsnaa Diagnostics does not expect to raise any new debt for planned CAPEX.
  • CAPEX is primarily funded through internal accruals and some vendor financing (deferred payment or leasing of equipment).
  • Debt raising is considered only if a new tender warrants it.
  • There is no mention of imminent equity fundraising.
  • Cash on the balance sheet (~220 crores) will be utilized for working capital.
  • Future fundraising decisions will depend on new tender opportunities and project requirements.

See what Krsnaa Diagnostics management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Total CAPEX guidance for FY24 and FY25 is approximately ₹120-130 crore each year, totaling around ₹240-260 crore over two years.
  • Rajasthan tender alone has a projected CAPEX of close to ₹200 crore, with major spending planned in H2 FY24 and Q1 FY25.
  • CAPEX for other projects like Odisha, Assam, and Punjab is relatively lower, estimated around ₹40-60 crore.
  • The company primarily plans to fund CAPEX through internal accruals and vendor financing (deferred payment or lease of equipment).
  • No major debt raises planned for CAPEX unless new tenders require it.
  • Strategic investments focus on deploying equipment and setting up infrastructure in new government PPP projects, including Rajasthan, Assam, Odisha, Maharashtra, and BMC contracts.
  • CAPEX is mainly for setting up collection centers, pathology labs, and radiology equipment as per government tender requirements.

Track Krsnaa Diagnostics — get its next earnings analysis in your feed

How does Krsnaa Diagnostics rank vs peers in Healthcare Services?

Pro feature
ThisKrsnaa Diagnostics
Rev 2Mar 3

How does Krsnaa Diagnostics rank in Healthcare Services?

Compare Krsnaa Diagnostics against every Healthcare Services company (Q1 FY24) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

Others in Healthcare Services this season

  • Chandan Healthca (Q2 FY27)

    Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor

  • Invicta Diagnostic (Q2 FY27)

    Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2

  • Unihealth Hosp (Q2 FY27)

    1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r

  • Sangani Hospital (Q2 FY27)

    1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →